Does Semaglutide Give You Constipation? How to Tell

Written by: Taylor Cottle, PhD |August 18, 2026

Time to read 6 minutes

Does Semaglutide Give You Constipation? How to Tell

Does Semaglutide Give You Constipation? How to Read Your Own Signal

Open notebook and pen for tracking bowel habit symptoms

Semaglutide's placebo-controlled trials in adults treated for weight management put constipation at 24% on Wegovy versus 11% on placebo, a gap wide enough that it's a common experience rather than an outlier reaction¹. Whether it's what's happening to you this week is a different question, and it comes down to your own dose timing, stool type, and daily habits rather than the topline trial number.

What Semaglutide-Related Constipation Usually Looks Like

Clinically, constipation isn't just "I didn't go today." The NIDDK defines it around four things: fewer than three bowel movements a week, stools that are hard, dry, or lumpy, stools that are difficult or painful to pass, and a lingering feeling that you didn't fully empty³. Missing an occasional day, without hard or painful stools, straining, or that unfinished feeling, doesn't by itself add up to constipation by these criteria.

With semaglutide specifically, a few features tend to travel together:

Frequency drops, sometimes gradually, sometimes within days of a dose change.
Stool gets firmer and harder to pass, not just less frequent.
You're straining more, or spending longer on the toilet than usual.
A sense of not finishing, even right after you've gone.
Bloating or a feeling of fullness/distension. This is easy to chalk up to the drug slowing your appetite, but it's a separately tabulated side effect too: abdominal distension was reported by 7% on Wegovy versus 5% on placebo, and flatulence by 6% versus 4%¹. The trial data reports these rates separately rather than tracking who had which symptoms together, so it doesn't confirm the two occur in the same people, but both are common enough on semaglutide to be worth noting if you have them.

No single item on this list proves semaglutide is the cause, but several showing up together after a dose change is worth tracking.

Check Your Dose Calendar First

Checking your dose calendar is one of the more useful things you can do before assuming anything else. In a post hoc analysis of pooled data from the STEP 1-3 trials, funded by Novo Nordisk and including Novo Nordisk employees and shareholders among its authors², GI side effects including constipation were reported more often during the dose-escalation period than later in treatment. A change in bathroom habits after a dose increase is worth paying attention to, though timing alone can't confirm the cause.

Duration matters too. In that same pooled analysis, constipation on semaglutide lasted a median of 47 days per episode, compared with 35 days on placebo². Nausea, vomiting, and diarrhea, by contrast, tend to peak around week 20 of treatment and then ease off, while constipation typically levels off earlier, around week 10, and then stays modestly more common than placebo for the rest of the study period². So if your stomach symptoms calmed down months ago but your bowels are still sluggish, that timing lines up with how semaglutide tends to behave in these trials, though ongoing constipation is still worth mentioning at your next appointment, especially if it's new or getting worse.

Use the Bristol Stool Chart to Read Your Own Signal

You don't need a lab test to get useful information out of your own bathroom habits. The Bristol Stool Form Scale, a simple 7-point picture scale, was validated in 66 volunteers whose transit time, measured with radiopaque markers, was deliberately sped up or slowed down with senna and loperamide; stool form tracked those changes closely⁴. Type 1 (hard separate lumps) and Type 2 (lumpy, sausage-shaped) point toward slower transit; Type 3 and 4 are the normal range; Type 6 and 7 point the other direction.

Researchers studying probiotics for people with functional GI symptoms have used stool type 2-4 on this same scale, alongside a bowel-movement frequency requirement, as part of their enrollment criteria⁵, a scale that's used in day-to-day clinical practice, not just research⁴. Glance at a Bristol chart image (a quick search will pull one up) and note your type for a few days. If you've drifted from a 3-4 baseline to mostly 1-2, that shift is a meaningful sign transit has slowed: in the scale's original validation study, stool form tracked changes in transit time more closely than how often people went⁴.

A Simple Log That Makes the Pattern Obvious

Two weeks of daily notes gives you a clearer pattern than judging from one rough week. Keep it low-effort: a notes app works fine.

Each day, jot down:

Did you have a bowel movement? (Y/N)
Bristol type (1-7)
Straining, on a 0-3 scale
Bloating/fullness, on a 0-3 scale
Fluids: rough glasses of water
Fiber: did today's meals include much, or almost none
Movement: any walk or exercise
Semaglutide dose day, and whether it was a dose increase

After two weeks, look for patterns. If low-fluid days line up with your worst Bristol scores, that's something you can act on directly. If your roughest days consistently follow a dose increase, that points toward the medication as a contributing factor. If the fiber column is the one that's consistently thin, that's a specific, fixable gap, a fiber supplement built for a slower gut (more on that below) closes it faster than trying to eat your way there on a suppressed appetite. Bring this same log to a doctor or pharmacist if things don't improve; it gives them useful detail to work with.

When It's Probably Not (Just) the Semaglutide

A few things commonly stack on top of GLP-1-related slowing, and they're worth ruling out before you assume the drug is fully to blame. The NIDDK lists several medication classes that independently worsen constipation, including aluminum- or calcium-containing antacids, iron supplements, calcium channel blockers, and certain antidepressants³. Several of these are commonly prescribed in midlife, the age range where GLP-1 use is concentrated, so it's worth checking your other medications, not just your semaglutide dose. NIDDK also names low fiber intake and inadequate fluids as contributors in their own right³, separate from anything semaglutide does mechanically; both can drop when appetite is suppressed, which is common on these drugs.

A different category of symptoms means something else may be going on, and it's time to get evaluated rather than keep tracking. See a doctor right away if constipation shows up with rectal bleeding or blood in the stool, constant abdominal pain, inability to pass gas, vomiting, fever, lower back pain, or unintentional weight loss³. On the medication side, both Ozempic's and Wegovy's current prescribing information list ileus, intestinal obstruction, and severe constipation including fecal impaction among postmarketing gastrointestinal reports^1,6. These are reports from real-world use rather than a measured rate in a trial, so there's no solid number for how often they happen. Don't try to wait them out with more fiber and water. If your symptoms match any of the red flags above, or you haven't had a bowel movement in several days combined with pain or vomiting, call your doctor or go to urgent care.

What Helps While You Track It

For everything short of a red flag, the basics are still the starting point: steady water intake through the day (not just at meals, when appetite is already down), fiber spread across meals rather than dumped in all at once, and short walks, since staying active is one of the general measures NIDDK lists for constipation³.

When semaglutide dulls appetite, fiber intake is often the first thing that quietly falls off a plate. That gap is the exact problem we designed WonderBiotics Daily Fiber Mix to solve: rather than reaching for whatever fiber supplement is on the shelf, ours leads with slower-fermenting fibers, Fibersol (a soluble corn fiber) and partially hydrolyzed guar gum, specifically because a gut that's already moving slowly on semaglutide doesn't need the extra gas load that fast-fermenting fibers bring. Psyllium husk, kale fiber, and FOS round out the blend for its prebiotic effect, in 6-gram sachets you mix into coffee, a smoothie, or yogurt, an easy habit to log alongside the water, movement, and dose-day notes above, and a natural thing to bring up with your prescriber if your log points to a fiber gap worth closing together.